
Mary Mosher
Examiner (ID: 8389)
| Most Active Art Unit | 1648 |
| Art Unit(s) | 1813, 1815, 1643, 2899, 1648, 1641, 1804, 1609, 1805 |
| Total Applications | 1434 |
| Issued Applications | 907 |
| Pending Applications | 126 |
| Abandoned Applications | 404 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 5464393
[patent_doc_number] => 20090324593
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-12-31
[patent_title] => 'Humanized antibodies against west nile virus and therapeutic and prophylactic uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/457447
[patent_app_country] => US
[patent_app_date] => 2009-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 42848
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0324/20090324593.pdf
[firstpage_image] =>[orig_patent_app_number] => 12457447
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/457447 | Humanized antibodies against west nile virus and therapeutic and prophylactic uses thereof | Jun 10, 2009 | Abandoned |
Array
(
[id] => 6024301
[patent_doc_number] => 20110052627
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-03
[patent_title] => 'RECOMBINANT MODIFIED VACCINIA VIRUS MEASLES VACCINE'
[patent_app_type] => utility
[patent_app_number] => 12/937412
[patent_app_country] => US
[patent_app_date] => 2009-06-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 26
[patent_figures_cnt] => 26
[patent_no_of_words] => 21307
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0052/20110052627.pdf
[firstpage_image] =>[orig_patent_app_number] => 12937412
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/937412 | RECOMBINANT MODIFIED VACCINIA VIRUS MEASLES VACCINE | Jun 7, 2009 | Abandoned |
Array
(
[id] => 4598622
[patent_doc_number] => 07976850
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-07-12
[patent_title] => 'Pox viridae treatment'
[patent_app_type] => utility
[patent_app_number] => 12/474331
[patent_app_country] => US
[patent_app_date] => 2009-05-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 6272
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 54
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/976/07976850.pdf
[firstpage_image] =>[orig_patent_app_number] => 12474331
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/474331 | Pox viridae treatment | May 28, 2009 | Issued |
Array
(
[id] => 8469627
[patent_doc_number] => 08298805
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-10-30
[patent_title] => 'Signal for packaging of influenza virus vectors'
[patent_app_type] => utility
[patent_app_number] => 12/470287
[patent_app_country] => US
[patent_app_date] => 2009-05-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 42
[patent_no_of_words] => 24328
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 250
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 12470287
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/470287 | Signal for packaging of influenza virus vectors | May 20, 2009 | Issued |
Array
(
[id] => 5490357
[patent_doc_number] => 20090291428
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-26
[patent_title] => 'COMPOSITIONS AND METHODS FOR THE DETECTION AND TREATMENT OF POXVIRAL INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 12/469535
[patent_app_country] => US
[patent_app_date] => 2009-05-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 32
[patent_figures_cnt] => 32
[patent_no_of_words] => 15957
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0291/20090291428.pdf
[firstpage_image] =>[orig_patent_app_number] => 12469535
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/469535 | COMPOSITIONS AND METHODS FOR THE DETECTION AND TREATMENT OF POXVIRAL INFECTIONS | May 19, 2009 | Abandoned |
Array
(
[id] => 6340234
[patent_doc_number] => 20100247572
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-30
[patent_title] => 'VIRUSES ENCODING MUTANT MEMBRANE PROTEIN'
[patent_app_type] => utility
[patent_app_number] => 12/467492
[patent_app_country] => US
[patent_app_date] => 2009-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 28
[patent_figures_cnt] => 28
[patent_no_of_words] => 15738
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0247/20100247572.pdf
[firstpage_image] =>[orig_patent_app_number] => 12467492
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/467492 | VIRUSES ENCODING MUTANT MEMBRANE PROTEIN | May 17, 2009 | Abandoned |
Array
(
[id] => 5551776
[patent_doc_number] => 20090285762
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-11-19
[patent_title] => 'IMAGING METHODS AND COMPOSITIONS COMPRISING FLUORESCENT DYES ASSOCIATED WITH VIRAL COMPONENTS FOR NERVE IMAGING'
[patent_app_type] => utility
[patent_app_number] => 12/466122
[patent_app_country] => US
[patent_app_date] => 2009-05-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 12
[patent_figures_cnt] => 12
[patent_no_of_words] => 9441
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0285/20090285762.pdf
[firstpage_image] =>[orig_patent_app_number] => 12466122
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/466122 | Imaging methods and compositions comprising fluorescent dyes associated with viral components for nerve imaging | May 13, 2009 | Issued |
Array
(
[id] => 5984826
[patent_doc_number] => 20110097417
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-28
[patent_title] => 'MELAN-A-CARRIER CONJUGATES'
[patent_app_type] => utility
[patent_app_number] => 12/463985
[patent_app_country] => US
[patent_app_date] => 2009-05-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 47822
[patent_no_of_claims] => 39
[patent_no_of_ind_claims] => 21
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0097/20110097417.pdf
[firstpage_image] =>[orig_patent_app_number] => 12463985
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/463985 | MELAN-A-CARRIER CONJUGATES | May 10, 2009 | Abandoned |
Array
(
[id] => 4624019
[patent_doc_number] => 08003314
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-08-23
[patent_title] => 'Methods for direct fluorescent antibody virus detection in liquids'
[patent_app_type] => utility
[patent_app_number] => 12/425256
[patent_app_country] => US
[patent_app_date] => 2009-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 30310
[patent_no_of_claims] => 81
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 137
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/003/08003314.pdf
[firstpage_image] =>[orig_patent_app_number] => 12425256
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/425256 | Methods for direct fluorescent antibody virus detection in liquids | Apr 15, 2009 | Issued |
Array
(
[id] => 6038451
[patent_doc_number] => 20110091500
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-04-21
[patent_title] => 'Inactivated Live-Attenuated Bluetongue Virus Vaccine'
[patent_app_type] => utility
[patent_app_number] => 12/988282
[patent_app_country] => US
[patent_app_date] => 2009-04-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 6132
[patent_no_of_claims] => 21
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0091/20110091500.pdf
[firstpage_image] =>[orig_patent_app_number] => 12988282
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/988282 | Inactivated Live-Attenuated Bluetongue Virus Vaccine | Apr 15, 2009 | Abandoned |
Array
(
[id] => 5457859
[patent_doc_number] => 20090258011
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-10-15
[patent_title] => 'Antibodies against west nile virus and therapeutic and prophylactic uses thereof'
[patent_app_type] => utility
[patent_app_number] => 12/385346
[patent_app_country] => US
[patent_app_date] => 2009-04-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 22
[patent_figures_cnt] => 22
[patent_no_of_words] => 49499
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0258/20090258011.pdf
[firstpage_image] =>[orig_patent_app_number] => 12385346
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/385346 | Antibodies against West Nile Virus and therapeutic and prophylactic uses thereof | Apr 5, 2009 | Issued |
Array
(
[id] => 8027881
[patent_doc_number] => 08143020
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2012-03-27
[patent_title] => 'Enhanced metabolite generation'
[patent_app_type] => utility
[patent_app_number] => 12/417881
[patent_app_country] => US
[patent_app_date] => 2009-04-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 3
[patent_no_of_words] => 5222
[patent_no_of_claims] => 29
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 79
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/143/08143020.pdf
[firstpage_image] =>[orig_patent_app_number] => 12417881
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/417881 | Enhanced metabolite generation | Apr 2, 2009 | Issued |
Array
(
[id] => 6479557
[patent_doc_number] => 20100041740
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-02-18
[patent_title] => 'FLU VACCINES AND METHODS OF USE THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/417556
[patent_app_country] => US
[patent_app_date] => 2009-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 30
[patent_figures_cnt] => 30
[patent_no_of_words] => 20439
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0041/20100041740.pdf
[firstpage_image] =>[orig_patent_app_number] => 12417556
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/417556 | Flu vaccines and methods of use thereof | Apr 1, 2009 | Issued |
Array
(
[id] => 5385241
[patent_doc_number] => 20090226486
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2009-09-10
[patent_title] => 'N protein mutants of porcine reproductive and respiratory syndrome virus'
[patent_app_type] => utility
[patent_app_number] => 12/383937
[patent_app_country] => US
[patent_app_date] => 2009-03-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 11464
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0226/20090226486.pdf
[firstpage_image] =>[orig_patent_app_number] => 12383937
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/383937 | N protein mutants of porcine reproductive and respiratory syndrome virus | Mar 29, 2009 | Issued |
Array
(
[id] => 6349444
[patent_doc_number] => 20100249043
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-30
[patent_title] => 'COMPOSITIONS AND METHODS FOR PROMOTING HAIR GROWTH'
[patent_app_type] => utility
[patent_app_number] => 12/413436
[patent_app_country] => US
[patent_app_date] => 2009-03-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 3043
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0249/20100249043.pdf
[firstpage_image] =>[orig_patent_app_number] => 12413436
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/413436 | COMPOSITIONS AND METHODS FOR PROMOTING HAIR GROWTH | Mar 26, 2009 | Abandoned |
Array
(
[id] => 6202309
[patent_doc_number] => 20110065095
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-17
[patent_title] => 'ANTI-(INFLUENZA A VIRUS SUBTYPE H5 HEMAGGLUTININ) MONOCLONAL ANTIBODY'
[patent_app_type] => utility
[patent_app_number] => 12/934908
[patent_app_country] => US
[patent_app_date] => 2009-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 12529
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20110065095.pdf
[firstpage_image] =>[orig_patent_app_number] => 12934908
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/934908 | Anti-(influenza a virus subtype H5 hemagglutinin) monoclonal antibody | Mar 25, 2009 | Issued |
Array
(
[id] => 6353429
[patent_doc_number] => 20100086564
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-08
[patent_title] => 'West Nile Virus Vaccine'
[patent_app_type] => utility
[patent_app_number] => 12/409120
[patent_app_country] => US
[patent_app_date] => 2009-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 5765
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0086/20100086564.pdf
[firstpage_image] =>[orig_patent_app_number] => 12409120
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/409120 | West nile virus vaccine | Mar 22, 2009 | Issued |
Array
(
[id] => 6228909
[patent_doc_number] => 20100183647
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-22
[patent_title] => 'Novel human cytomegalovirus (HCMV) cytotoxic T cell epitopes, polyepitopes, compositions comprising same and diagnostic and prophylactic and therapeutic uses therefor'
[patent_app_type] => utility
[patent_app_number] => 12/382425
[patent_app_country] => US
[patent_app_date] => 2009-03-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 36
[patent_figures_cnt] => 36
[patent_no_of_words] => 34955
[patent_no_of_claims] => 43
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0183/20100183647.pdf
[firstpage_image] =>[orig_patent_app_number] => 12382425
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/382425 | Novel human cytomegalovirus (HCMV) cytotoxic T cell epitopes, polyepitopes, compositions comprising same and diagnostic and prophylactic and therapeutic uses therefor | Mar 15, 2009 | Abandoned |
Array
(
[id] => 6202307
[patent_doc_number] => 20110065093
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-17
[patent_title] => 'NOVEL TOOL FOR THE ANALYSIS OF NEURAL CIRCUITS'
[patent_app_type] => utility
[patent_app_number] => 12/921865
[patent_app_country] => US
[patent_app_date] => 2009-03-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7279
[patent_no_of_claims] => 7
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0065/20110065093.pdf
[firstpage_image] =>[orig_patent_app_number] => 12921865
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/921865 | NOVEL TOOL FOR THE ANALYSIS OF NEURAL CIRCUITS | Mar 8, 2009 | Abandoned |
Array
(
[id] => 7987219
[patent_doc_number] => 08075903
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-12-13
[patent_title] => 'Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4 or antigenic chimeric dengue viruses 1, 2, 3, and 4'
[patent_app_type] => utility
[patent_app_number] => 12/398043
[patent_app_country] => US
[patent_app_date] => 2009-03-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 19
[patent_no_of_words] => 30973
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 222
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/075/08075903.pdf
[firstpage_image] =>[orig_patent_app_number] => 12398043
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/398043 | Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4 or antigenic chimeric dengue viruses 1, 2, 3, and 4 | Mar 3, 2009 | Issued |